Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 61–75 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3817 ANG Gene Amyotrophic Lateral Sclerosis Type 9 Genetic Test This test evaluates the angiogenin (ANG) gene for pathogenic variants associated with Amyotrophic Lateral Sclerosis Type 9 (ALS9).	Peripheral whole blood (EDTA) or extracted DNA	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ANG gene", "Copy number variants (CNVs) in the ANG gene"] Parameters [] Preparation [] Indications ["Individuals presenting with progressive motor weakness", "Individuals with a family history suggestive of ALS type 9"] Measurement technique Confirm with laboratory Codes LOINC: 77772-5 ICD-10: G12.21 Clinical summary This test evaluates the angiogenin (ANG) gene for pathogenic variants associated with Amyotrophic Lateral Sclerosis Type 9 (ALS9).
TEST-3178 ANKRD26 Gene Thrombocytopenia Type 2 Genetic Test This genetic test detects pathogenic variants in the ANKRD26 gene associated with inherited thrombocytopenia type 2 (THC2), a bleeding disorder.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ANKRD26 gene", "Point mutations", "Small insertions and deletions", "Copy number changes"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counselling is mandatory"] Indications ["Suspected inherited thrombocytopenia type 2", "Family history of low platelet counts or bleeding disorders", "Confirmation of diagnosis in symptomatic individuals", "Predictive testing for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 21673-3 ICD-10: D69.4 Clinical summary This genetic test detects pathogenic variants in the ANKRD26 gene associated with inherited thrombocytopenia type 2 (THC2), a bleeding disorder.
TEST-3656 ANKS6 Gene Nephronophthisis Type 16 Genetic Test This genetic test identifies pathogenic variants in the ANKS6 gene associated with Nephronophthisis Type 16, a form of juvenile cystic kidney disease.	Whole Blood, Extracted DNA, FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ANKS6 gene"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected Nephronophthisis Type 16", "Family history of juvenile cystic kidney disease", "Early diagnosis of renal disease"] Measurement technique Confirm with laboratory Codes LOINC: 97728-8 ICD-10: Q61.5 Clinical summary This genetic test identifies pathogenic variants in the ANKS6 gene associated with Nephronophthisis Type 16, a form of juvenile cystic kidney disease.
TEST-2080 ANTXR1 Gene Hemangioma Capillary Infantile Genetic Test (NGS) This test evaluates the ANTXR1 gene for pathogenic variants associated with capillary infantile hemangioma.	Peripheral whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ANTXR1 gene", "Insertions", "Deletions", "Splice-site alterations"] Parameters [] Preparation [] Indications ["Diagnosis of capillary infantile hemangioma", "Genetic counseling for families with ANTXR1-related syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q82.8 Clinical summary This test evaluates the ANTXR1 gene for pathogenic variants associated with capillary infantile hemangioma.
TEST-6183 AP2S1 Gene Familial Hypocalciuric Hypercalcemia Type 3 Genetic Test This genetic test analyzes the AP2S1 gene for mutations causing Familial Hypocalciuric Hypercalcemia Type 3 (FHH3). It helps differentiate FHH3 from primary hyperparathyroidism.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AP2S1 gene", "Full exon and splice-site coverage"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions (within 4 weeks)"] Indications ["Diagnosis of FHH3", "Family cascade screening for FHH3", "Differentiation from primary hyperparathyroidism"] Measurement technique Confirm with laboratory Codes LOINC: 94492-9 ICD-10: ['E83.52', 'E83.51', 'Z13.79'] Clinical summary This genetic test analyzes the AP2S1 gene for mutations causing Familial Hypocalciuric Hypercalcemia Type 3 (FHH3). It helps differentiate FHH3 from primary hyperparathyroidism.
TEST-5668 AP4B1 Gene (SPG47) Next-Generation Sequencing (NGS) Genetic Test This test identifies mutations in the AP4B1 gene associated with Hereditary Spastic Paraplegia Type 47 (SPG47).	Whole blood (3–5 mL in EDTA tube), pre-extracted genomic DNA (≥1 µg at ≥50 ng/µL), or dried blood spot on FTA card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AP4B1 gene coding sequence", "Pathogenic point mutations", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["No fasting or special preparation needed"] Indications ["Diagnosis of Hereditary Spastic Paraplegia Type 47 (SPG47)", "Patients with clinical features suggestive of SPG47"] Measurement technique Confirm with laboratory Codes LOINC: 94243-0 ICD-10: G11.4 Clinical summary This test identifies mutations in the AP4B1 gene associated with Hereditary Spastic Paraplegia Type 47 (SPG47).
TEST-5987 APOA1 Gene Amyloidosis, Familial Visceral Genetic Test This genetic test screens for pathogenic variants in the APOA1 gene associated with familial visceral amyloidosis.	Whole Blood (EDTA) or FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the APOA1 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No specific fasting required.", "Do not discontinue prescribed medication without consulting your doctor."] Indications ["Confirmation of suspected familial visceral amyloidosis", "Genetic risk assessment for family members of affected individuals", "Evaluation of unexplained organ dysfunction potentially related to amyloid deposition"] Measurement technique Confirm with laboratory Codes LOINC: 21647-2 ICD-10: E85.0 Clinical summary This genetic test screens for pathogenic variants in the APOA1 gene associated with familial visceral amyloidosis.
TEST-6197 APOB Gene Hypercholesterolaemia Type B (Autosomal Dominant) Genetic Test This genetic test identifies pathogenic variants in the APOB gene associated with autosomal dominant familial hypercholesterolaemia type B.	Whole blood (EDTA), extracted DNA, or dried blood spot on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the APOB gene", "Genetic predisposition to hypercholesterolaemia type B"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed unless advised by physician"] Indications ["Diagnosis of autosomal dominant familial hypercholesterolaemia type B", "Cardiovascular risk stratification", "Cascade testing for family members"] Measurement technique Confirm with laboratory Codes LOINC: 94046-6 ICD-10: E78.01 Clinical summary This genetic test identifies pathogenic variants in the APOB gene associated with autosomal dominant familial hypercholesterolaemia type B.
TEST-328 APOE Genotyping Test This test evaluates genetic variations in the apolipoprotein E gene (APOE) associated with Alzheimer's disease and cardiovascular risk.	Whole blood (EDTA tube, 4 mL)	10 Working Days	4,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["APOE gene variations (ε2, ε3, ε4 alleles)"] Parameters [] Preparation [] Indications ["Risk assessment for late-onset Alzheimer's disease", "Assessment of genetic predisposition to cardiovascular conditions"] Measurement technique Confirm with laboratory Codes LOINC: 21637-2 ICD-10: Z13.858 Clinical summary This test evaluates genetic variations in the apolipoprotein E gene (APOE) associated with Alzheimer's disease and cardiovascular risk.
TEST-3005 AR Gene Hypospadias Type 1, X-Linked Genetic Test This diagnostic test evaluates the androgen receptor (AR) gene for pathogenic variants associated with X-linked hypospadias type 1.	Whole Blood (Lavender Top EDTA Tube) or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AR gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusions"] Indications ["Diagnosis of X-linked hypospadias type 1", "Genetic counseling for families with affected individuals", "Prenatal diagnosis in high-risk pregnancies"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q54.0 Clinical summary This diagnostic test evaluates the androgen receptor (AR) gene for pathogenic variants associated with X-linked hypospadias type 1.
TEST-3903 ARL6 Gene Bardet‑Biedl Syndrome Type 3 Genetic Test This test analyzes the ARL6 gene for pathogenic variants associated with Bardet‑Biedl Syndrome Type 3.	Whole blood (2‑5 mL in EDTA tube), extracted DNA (≥1 µg), or one drop of blood on FTA card	3‑4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARL6 gene"] Parameters [] Preparation ["A detailed clinical history and a genetic counseling session to draw a pedigree chart of affected family members are required before sample collection."] Indications ["Diagnostic confirmation of Bardet‑Biedl Syndrome Type 3", "Family screening for ARL6 variants"] Measurement technique Confirm with laboratory Codes LOINC: 51990-0 ICD-10: Q87.8 Clinical summary This test analyzes the ARL6 gene for pathogenic variants associated with Bardet‑Biedl Syndrome Type 3.
TEST-5027 ARX Gene Mental Retardation, X‑Linked Type 29 Genetic Test This test evaluates the ARX gene for pathogenic variants associated with X-linked intellectual disability type 29 and related neurological conditions.	Peripheral Whole Blood (1–2 mL EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARX gene", "Point mutations", "Small insertions/deletions (indels)", "Splice variants"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist if child cannot tolerate venipuncture for FTA card collection"] Indications ["Diagnosis of X-linked intellectual disability type 29", "Carrier testing in females with family history", "Evaluation of developmental delay, seizures, or movement disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94221-1 ICD-10: F78.9 Clinical summary This test evaluates the ARX gene for pathogenic variants associated with X-linked intellectual disability type 29 and related neurological conditions.
TEST-6294 ASAH1 Gene Sequencing for Farber Disease (Genetic Test) This test sequences the ASAH1 gene to detect pathogenic variants associated with Farber lipogranulomatosis.	Whole blood (EDTA tube), extracted DNA, or FTA card	3–4 weeks (with genetic counselling)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ASAH1 gene", "Copy Number Variations (CNV) in ASAH1"] Parameters [] Preparation ["No specific fasting required", "Genetic counselling session required before testing"] Indications ["Suspicion of Farber lipogranulomatosis", "Family history of Farber disease", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81201-4 ICD-10: E75.22 Clinical summary This test sequences the ASAH1 gene to detect pathogenic variants associated with Farber lipogranulomatosis.
TEST-3669 ASB10 Gene Glaucoma, Open-Angle Type 1F Genetic Test This genetic test evaluates the ASB10 gene for pathogenic variants associated with primary open-angle glaucoma (POAG). It identifies individuals at increased lifetime risk for deve...	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ASB10 gene", "Genetic predisposition to Primary Open-Angle Glaucoma (POAG)"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Individuals with a first-degree relative diagnosed with POAG", "Risk stratification for POAG", "Personalized management planning"] Measurement technique Confirm with laboratory Codes LOINC: 104198-4 ICD-10: H40.11, Z13.5 Clinical summary This genetic test evaluates the ASB10 gene for pathogenic variants associated with primary open-angle glaucoma (POAG). It identifies individuals at increased lifetime risk for developing this condition.
TEST-6017 ASNS Gene Asparagine Synthetase Deficiency Genetic Test This genetic test identifies pathogenic variants in the ASNS gene, confirming asparagine synthetase deficiency.	Whole Blood (Peripheral)	3–4 Weeks (expedited possible)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ASNS gene", "SNVs, indels, and CNVs"] Parameters [] Preparation ["No fasting is required.", "A mandatory pre-genetic counselling session is conducted."] Indications ["Clinical suspicion of asparagine synthetase deficiency", "Patients with microcephaly, refractory epilepsy, and developmental delay"] Measurement technique Confirm with laboratory Codes LOINC: 94495-4 ICD-10: E79.8 Clinical summary This genetic test identifies pathogenic variants in the ASNS gene, confirming asparagine synthetase deficiency.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.